NCT05547152

Brief Summary

Peripheral facial palsy affects 15 to 40 people per 100,000 inhabitants and induces important functional and social repercussions. Synkinesis is a frequent after-effect of facial palsy recovery, consisting of involuntary facial spasms that disturb the gestural harmony and can go as far as a painful hypertonic spasm. More than 55% of patients recovering from facial palsy will develop transient or permanent synkinesis. These facial hypertonias have two main causes: imperfect axonal regeneration, which is all the more important as the damage is proximal, and hyperexcitability of the facial nerve nucleus due to a lack of central control. Management is therefore essential for the functional restoration of the face, especially since synkinesis do not evolve spontaneously. The main treatments are currently botulinum toxin injection, acting on the motor plate, and functional rehabilitation, consisting on local muscle relaxation and central motor control work. In recent years, therapies based on biofeedback and acting on central motor control have shown interesting results, and technological advances in virtual reality have made it possible to deepen this treatment in patients suffering from stroke, limb trauma or Parkinson's disease. In this project, the investigators evaluate the contribution of virtual reality to the management of facial palsy, and hypothesize that self-rehabilitation using this technology will improve motor control of the skin muscles and reduce complications related to their hypertonia such as synkinesis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

September 6, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 21, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

September 21, 2022

Status Verified

September 1, 2022

Enrollment Period

2 years

First QC Date

September 6, 2022

Last Update Submit

September 15, 2022

Conditions

Keywords

Peripheral Facial Palsyrehabilitationvirtual reality

Outcome Measures

Primary Outcomes (1)

  • variation of number of involuntary facial spasm between both groups of patients

    variation of synkinesis in patients with recent onset (≤ 12 months) peripheral facial palsy compared with the conventional rehabilitation protocol

    12 months

Study Arms (2)

Experimental arm

EXPERIMENTAL

patients benefiting from rehabilitation associated with virtual reality

Other: massagesOther: motor stimulation and stretchingOther: virtual reality

Control arm

ACTIVE COMPARATOR

patients benefiting from rehabilitation without virtual reality

Other: massagesOther: motor stimulation and stretching

Interventions

The experimental rehabilitation protocol includes massages

Control armExperimental arm

motor stimulation and stretching

Control armExperimental arm

Patient watches an avatar of his face performing different movements on a screen, and will have to imagine performing these movements without actually doing them.

Experimental arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient with recent onset peripheral facial palsy (≤ 12 months).
  • Patient with peripheral facial palsy of grade ≥ III on the House \& Brackmann score
  • Patient of legal age (≥ 18 years)
  • Patient with appropriate information and informed consent

You may not qualify if:

  • Patient with central facial palsy
  • Patient with peripheral facial palsy of \> 12 months onset
  • Patient with peripheral facial palsy of grade \< III House \& Brackmann score
  • Patient who has previously undergone palliative surgery
  • Patient undergoing a botulinum toxin injection protocol
  • Patients benefiting from enhanced protection, i.e. minors, persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social institution, adults under legal protection, pregnant or breast-feeding women and patients in emergency situations
  • Patients who have not provided informed consent
  • Patients with cognitive disorders that do not allow them to follow the proposed self-education protocol
  • Blind or visually impaired patients (visual acuity of the better eye after correction ≤ 4/10)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Amiens Picardie

Amiens, Picardie, 80054, France

RECRUITING

MeSH Terms

Interventions

Massage

Intervention Hierarchy (Ancestors)

Therapy, Soft TissueMusculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2022

First Posted

September 21, 2022

Study Start

September 6, 2022

Primary Completion

September 1, 2024

Study Completion

September 1, 2025

Last Updated

September 21, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations